Virtus LifeSci Biotech Clinical Trials ETF (BBC)
NYSEARCA: BBC · Real-Time Price · USD
20.53
+0.78 (3.92%)
At close: Jun 6, 2025, 4:00 PM
20.53
0.00 (0.00%)
After-hours: Jun 6, 2025, 4:10 PM EDT
BBC Holdings List
As of Jun 4, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | AKRO | Akero Therapeutics, Inc. | 1.92% |
2 | SLNO | Soleno Therapeutics, Inc. | 1.75% |
3 | LQDA | Liquidia Corporation | 1.68% |
4 | ANAB | AnaptysBio, Inc. | 1.49% |
5 | MRUS | Merus N.V. | 1.46% |
6 | CVAC | CureVac N.V. | 1.46% |
7 | XERS | Xeris Biopharma Holdings, Inc. | 1.37% |
8 | ITOS | iTeos Therapeutics, Inc. | 1.35% |
9 | ETNB | 89bio, Inc. | 1.35% |
10 | PTGX | Protagonist Therapeutics, Inc. | 1.34% |
11 | MLYS | Mineralys Therapeutics, Inc. | 1.34% |
12 | TSHA | Taysha Gene Therapies, Inc. | 1.30% |
13 | RGNX | REGENXBIO Inc. | 1.21% |
14 | TNGX | Tango Therapeutics, Inc. | 1.20% |
15 | SANA | Sana Biotechnology, Inc. | 1.19% |
16 | SMMT | Summit Therapeutics Inc. | 1.15% |
17 | MNMD | Mind Medicine (MindMed) Inc. | 1.14% |
18 | ARQT | Arcutis Biotherapeutics, Inc. | 1.14% |
19 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13% |
20 | n/a | Bny Mellon Cash Reserve Usd | 1.12% |
21 | KYMR | Kymera Therapeutics, Inc. | 1.10% |
22 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.08% |
23 | BLTE | Belite Bio, Inc | 1.08% |
24 | CMPS | COMPASS Pathways plc | 1.08% |
25 | RNA | Avidity Biosciences, Inc. | 1.06% |
26 | QURE | uniQure N.V. | 1.04% |
27 | NGNE | Neurogene Inc. | 1.02% |
28 | ELVN | Enliven Therapeutics, Inc. | 1.02% |
29 | ZYME | Zymeworks Inc. | 1.01% |
30 | ABUS | Arbutus Biopharma Corporation | 1.01% |
31 | CELC | Celcuity Inc. | 1.00% |
32 | MLTX | MoonLake Immunotherapeutics | 1.00% |
33 | LENZ | LENZ Therapeutics, Inc. | 1.00% |
34 | NUVB | Nuvation Bio Inc. | 0.98% |
35 | CGON | CG Oncology, Inc. | 0.97% |
36 | CATX | Perspective Therapeutics, Inc. | 0.95% |
37 | RVMD | Revolution Medicines, Inc. | 0.94% |
38 | STOK | Stoke Therapeutics, Inc. | 0.93% |
39 | NUVL | Nuvalent, Inc. | 0.93% |
40 | AVBP | ArriVent BioPharma, Inc. | 0.92% |
41 | PHVS | Pharvaris N.V. | 0.92% |
42 | CAPR | Capricor Therapeutics, Inc. | 0.90% |
43 | VERV | Verve Therapeutics, Inc. | 0.89% |
44 | SLN | Silence Therapeutics plc | 0.87% |
45 | TRML | Tourmaline Bio, Inc. | 0.87% |
46 | APGE | Apogee Therapeutics, Inc. | 0.86% |
47 | ABCL | AbCellera Biologics Inc. | 0.86% |
48 | IDYA | IDEAYA Biosciences, Inc. | 0.86% |
49 | SNDX | Syndax Pharmaceuticals, Inc. | 0.85% |
50 | KROS | Keros Therapeutics, Inc. | 0.84% |
51 | REPL | Replimune Group, Inc. | 0.83% |
52 | VRDN | Viridian Therapeutics, Inc. | 0.83% |
53 | ACLX | Arcellx, Inc. | 0.82% |
54 | AUTL | Autolus Therapeutics plc | 0.82% |
55 | IMTX | Immatics N.V. | 0.81% |
56 | NAMS | NewAmsterdam Pharma Company N.V. | 0.81% |
57 | XENE | Xenon Pharmaceuticals Inc. | 0.81% |
58 | DNTH | Dianthus Therapeutics, Inc. | 0.80% |
59 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.79% |
60 | CLDX | Celldex Therapeutics, Inc. | 0.78% |
61 | CGEM | Cullinan Therapeutics, Inc. | 0.78% |
62 | SVRA | Savara Inc. | 0.78% |
63 | CNTA | Centessa Pharmaceuticals plc | 0.78% |
64 | SRRK | Scholar Rock Holding Corporation | 0.78% |
65 | IRON | Disc Medicine, Inc. | 0.77% |
66 | VIR | Vir Biotechnology, Inc. | 0.75% |
67 | VERA | Vera Therapeutics, Inc. | 0.74% |
68 | RXRX | Recursion Pharmaceuticals, Inc. | 0.74% |
69 | ARCT | Arcturus Therapeutics Holdings Inc. | 0.73% |
70 | GPCR | Structure Therapeutics Inc. | 0.73% |
71 | SYRE | Spyre Therapeutics, Inc. | 0.73% |
72 | IMNM | Immunome, Inc. | 0.72% |
73 | RAPP | Rapport Therapeutics, Inc. | 0.72% |
74 | MREO | Mereo BioPharma Group plc | 0.72% |
75 | TYRA | Tyra Biosciences, Inc. | 0.71% |
76 | COGT | Cogent Biosciences, Inc. | 0.71% |
77 | RLAY | Relay Therapeutics, Inc. | 0.71% |
78 | KURA | Kura Oncology, Inc. | 0.70% |
79 | MBX | MBX Biosciences, Inc. | 0.70% |
80 | CYTK | Cytokinetics, Incorporated | 0.68% |
81 | ALT | Altimmune, Inc. | 0.67% |
82 | ALLO | Allogene Therapeutics, Inc. | 0.67% |
83 | OLMA | Olema Pharmaceuticals, Inc. | 0.66% |
84 | BCAX | Bicara Therapeutics Inc. | 0.65% |
85 | DNLI | Denali Therapeutics Inc. | 0.65% |
86 | BEAM | Beam Therapeutics Inc. | 0.64% |
87 | GLUE | Monte Rosa Therapeutics, Inc. | 0.62% |
88 | NRIX | Nurix Therapeutics, Inc. | 0.62% |
89 | PRAX | Praxis Precision Medicines, Inc. | 0.61% |
90 | ERAS | Erasca, Inc. | 0.61% |
91 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.61% |
92 | NTLA | Intellia Therapeutics, Inc. | 0.59% |
93 | VKTX | Viking Therapeutics, Inc. | 0.59% |
94 | RCUS | Arcus Biosciences, Inc. | 0.59% |
95 | FDMT | 4D Molecular Therapeutics, Inc. | 0.58% |
96 | IMVT | Immunovant, Inc. | 0.58% |
97 | ANNX | Annexon, Inc. | 0.57% |
98 | ATXS | Astria Therapeutics, Inc. | 0.57% |
99 | TERN | Terns Pharmaceuticals, Inc. | 0.56% |
100 | DYN | Dyne Therapeutics, Inc. | 0.55% |
101 | EWTX | Edgewise Therapeutics, Inc. | 0.54% |
102 | TECX | Tectonic Therapeutic, Inc. | 0.51% |
103 | WVE | Wave Life Sciences Ltd. | 0.51% |
104 | ZNTL | Zentalis Pharmaceuticals, Inc. | 0.50% |
105 | RNAC | Cartesian Therapeutics, Inc. | 0.50% |
106 | THRD | Third Harmonic Bio, Inc. | 0.49% |
107 | CRVS | Corvus Pharmaceuticals, Inc. | 0.49% |
108 | PRME | Prime Medicine, Inc. | 0.46% |
109 | TRDA | Entrada Therapeutics, Inc. | 0.46% |
110 | BCYC | Bicycle Therapeutics plc | 0.44% |
111 | JANX | Janux Therapeutics, Inc. | 0.43% |
112 | BHVN | Biohaven Ltd. | 0.42% |
113 | LRMR | Larimar Therapeutics, Inc. | 0.42% |
114 | OMER | Omeros Corporation | 0.41% |
115 | PCVX | Vaxcyte, Inc. | 0.40% |
116 | XNCR | Xencor, Inc. | 0.39% |
117 | PRTA | Prothena Corporation plc | 0.37% |
118 | ARVN | Arvinas, Inc. | 0.37% |
119 | CRGX | CARGO Therapeutics, Inc. | 0.32% |
120 | RCKT | Rocket Pharmaceuticals, Inc. | 0.24% |
121 | IGMS | IGM Biosciences, Inc. | 0.16% |
122 | PLRX | Pliant Therapeutics, Inc. | 0.13% |
123 | NMRA | Neumora Therapeutics, Inc. | 0.08% |
124 | SCLX | Scilex Holding Company | 0.04% |
As of Jun 4, 2025